Financial report

the Interim financial statements for the six-month period ended 30 June 2018

Imexpharm respectfully inform our value investors and shareholders the INTERIM FINANCIAL STATEMENTS FOR THE SIX-MONTH PERIOD ENDED 30 JUNE 2018 Please download HERE

View details

Audited Financial Statements – Year ended 2017

AUDITED FINANCIAL STATEMENTS – For the year ended 31 December 2017 Please download here

View details

REVIEWED INTERIM FINANCIAL STATEMENTS

REVIEWED INTERIM FINANCIAL STATEMENTS For the 6-month period end 30 June 2017 Please download

View details

New product

pms- FlexoMax

Eternally, bone and joint problem is an issue in the community. In the past, this...

ATORVIS 20 thuốc hạ lipid

ATORVIS 20 thuốc hạ lipid Atorvastatin là thuốc hạ lipid máu thuộc nhóm statin - là...

pms-CLAMINAT 625MG

Amoxicillin là kháng sinh bán tổng hợp thuộc nhóm β - lactam có phổ diệt...

PMS-MEXCOLD 650

Đang cập nhật

INTRODUCTION VIDEO